Research

Our competitive edge is created by deep insight into the industries in which we operate and our knowledge of the trends and activities that affect our clients. In our chosen sectors, we regularly publish reviews of the dynamics and strategic initiatives driving M&A activity, private equity investment and debt capital deployment.

For more information on our research output, please contact Keith Pickering on    +44 (0)20 7246 0500 or keithpickering@catalystcf.co.uk

View all or

 

research cover Catalyst Pharma Fast 50

The inaugural Catalyst Pharma Fast 50, our list of the 50 fastest-growing privately owned pharmaceutical companies in the UK in 2016

PDF Catalyst Pharma Fast 50.pdf
Adobe Acrobat file - 7.5 mb
research cover UK Mental Health M&A 2014-2015 snapshot

The emergence of US trade buyers has energised the exit environment for owner managers and investors. We expect further consolidation over the next few years.

PDF UK Mental Health M&A 2014-2015 snapshot.pdf
Adobe Acrobat file - 0.7 mb
research cover Healthcare Sector M&A Update - Winter 2015/16

The past twelve months have seen a continuation of strong overall healthcare activity. Deal volumes across each sector have risen with pharmaceuticals recording a significant increase.

research cover Healthcare M&A 2015 snapshot

2015 saw a number of noticeable trends: pharma M&A and cross-border deals have grown significantly, and valuations continue to be strong for good businesses.

PDF Healthcare M&A 2015 snapshot.pdf
Adobe Acrobat file - 2.7 mb
research cover Healthcare Sector M&A Update - Spring 2015

The volume of deals in the first three months of 2015 have set the stage for a strong year with activity in pharmaceuticals and medtech higher than in the first quarter of 2014.

Next page >

‘Sustainability’, the key to today’s packaging market

If anyone was still unsure as to the direction the packaging industry is taking, the 2017 Packaging Innovations trade show left little doubt... 

Strong M&A outlook for mid-market pharma

The dynamics highlighted by this year’s Catalyst Pharma Fast 50 show that the sector is prime for further acquisitions and private equity investment... 

Why mid-market pharma is thriving

If there’s one thing that this year’s Pharma Fast 50 emphasises, it is that privately owned pharmaceutical firms in the UK are thriving... 

Optimism on post-Brexit renewables innovation

The sustainability challenges posed by the UK’s forthcoming exit of the EU were a central topic at this year's annual EIC Conference... 

Independent Vetcare – barking up the right tree

The vet market continues to attract plenty of interest. Independent Vetcare is currently being sold in what is rumoured to be a hotly contested auction... 

Catalyst advises LDC on the secondary buy-out of Addo Food Group

Catalyst has advised LDC and the management team on the secondary buy-out of Addo Food Group (Addo) the UK’s leading chilled savoury pastry producer, from Vision Capital.  

Catalyst hosts Q&A with West Midlands mayoral candidate Andy Street

Catalyst has hosted a Q&A with West Midland’s mayoral candidate Andy Street, at its Birmingham Office.  

Catalyst has advised the shareholders of UK Heating Group, including Encore Capital, on the sale to Irsap Group

Catalyst Corporate Finance has advised the shareholders of UK Heating Group, including Encore Capital, on the sale to Irsap Group. 

Catalyst advises the shareholders of Thompson & Morgan on the sale to BVG Group

Catalyst has advised the shareholders of Thompson & Morgan Group Holdings, including Primary Capital, on the sale to BVG Group 

Catalyst advises Phoenix Equity Partners on its investment in Global Freight Solutions

Catalyst has advised Phoenix Equity Partners on its investment in Global Freight Solutions (Holdings) Ltd (GFS) alongside the current management team, led by CEO Neil Cotty.